IgG4相关性疾病与特发性多中心型Castleman病的鉴别
本文综述了IgG4相关性疾病(IgG4-RD)与特发性多中心型Castleman病(iMCD)这两种罕见免疫介导性疾病的异同。两者发病机制不同,治疗策略分别为糖皮质激素/利妥昔单抗与靶向IL-6,但临床特征存在重叠,鉴别诊断需结合临床和病理发现,单一特征无法区分。
要点
- IgG4-RD与iMCD临床特征重叠,鉴别需结合临床和病理,单一特征无法区分。
- IgG4-RD关键特征为IgG4:IgG比值升高、过敏特征及Tfh细胞相关生发中心增生。
- iMCD特征为多克隆抗体产生(高IgA和IgM)、片状成熟浆细胞增生及IL-6驱动炎症。
核心结论
- IgG4-RD与iMCD是两种不同的免疫介导性疾病,发病机制和治疗策略不同,但临床特征重叠,鉴别诊断需结合临床和病理发现。
研究设计与样本
- 本文为综述,讨论IgG4-RD与iMCD的异同及鉴别方法。
主要发现
- IgG4-RD关键发现为IgG4:IgG比值升高、过敏特征和涉及Tfh细胞的生发中心增生。
- iMCD涉及多克隆抗体产生(高IgA和IgM水平)、片状成熟浆细胞增生和IL-6驱动的炎症特征。
- 两种疾病的器官受累分布也提供重要线索。
关键数值与推荐
- IgG4-RD治疗使用中等剂量糖皮质激素或利妥昔单抗。
- iMCD治疗涉及靶向IL-6的方法。
- 两种疾病的分类和诊断标准均要求仔细排除另一种疾病。
临床怎么用
- 临床鉴别IgG4-RD与iMCD应结合临床和/或病理发现,避免依赖单一特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IgG4-related disease (IgG4-RD) and idiopathic multicentric Castleman's disease (iMCD) are both rare systemic immune-mediated disorders. However, the pathogenesis differs markedly between the two diseases and differing therapeutic strategies are adopted: IgG4-RD is treated using a moderate dose of glucocorticoids or rituximab, while iMCD therapy involves an IL-6-targeted approach. Nonetheless, some clinical features of IgG4-RD and iMCD overlap, so differential diagnosis is sometimes difficult, even though the classification and diagnostic criteria of the diseases require careful exclusion of the other. The key findings in IgG4-RD are high IgG4:IgG ratio, allergic features and germinal centre expansion involving T follicular helper cells, while iMCD involves polyclonal antibody production (high IgA and IgM levels), sheet-like mature plasma cell proliferation and inflammatory features driven by IL-6. The distribution of organ involvement also provides important clues in both diseases. Particular attention should be given to differential diagnosis using combined clinical and/or pathological findings, because single features cannot distinguish IgG4-RD from iMCD. In the present review, we discuss the similarities and differences between IgG4-RD and iMCD, as well as how to distinguish the two diseases.
引用
- Sasaki T, Akiyama M, Kaneko Y, et al. Immunoglobulin G4-related disease and idiopathic multicentric Castleman's disease: confusable immune-mediated disorders. Rheumatology (Oxford). 2022. PMID: 34363463. doi:10.1093/rheumatology/keab634
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。